asapiprant: Clinical Trials

1 trial of asapiprant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow asapiprant: new trials by email Literature Review of asapiprant trials Research Report on asapiprant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure
BGE-175, Placebo - Covid19
Phase 2TerminatedBioAge Labs, Inc.1942021-03-182023-07-03

Conditions studied

COVID-19 (1)  ·  Respiratory Insufficiency (1)

Sponsors

BioAge Labs, Inc. (1)

Countries

Argentina (1)  ·  Brazil (1)  ·  United States (1)

Top investigators

Richard G Wilkerson, MD (1)